Principles of soft tissue augmentation for the aging face

被引:40
作者
Burgess, Cheryl M. [1 ]
机构
[1] Ctr Dermatol & Dermatol Surg, Washington, DC 20037 USA
关键词
soft tissue augmentation; fillers; fat atrophy hypertrophy; highly active anti-retroviral therapy; lipoatrophy;
D O I
10.2147/ciia.2006.1.4.349
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 [法学]; 0303 [社会学]; 100203 [老年医学];
摘要
In the quest for the "ideal" soft tissue filler, many diverse products have been developed. The expanding market of available fillers is a testament that no one product will ideally suit all patients or clinicians. In addition, the challenge of satisfying the criteria of an ideal filler has driven researchers to take a variety of development paths. This has resulted in multiple categories to characterize soft tissue fillers. These fillers are categorized according to: (1) filler material, eg, autologous, natural, synthetic; (2) mechanism of action, eg, void filler, neocollagenesis, fibroblast stimulation; (3) patient type and profile, eg, younger versus older patient, rhytids versus "sinking and sagging" skin; or (4) durability of treatment effects, eg, temporary, semi-permanent, or permanent. Although strategies for soft tissue augmentation may be quite diverse, strategies should share a universal goal to address fat redistribution (atrophy and hypertrophy), the primary underlying morphological cause of facial aging. To accomplish this, volumizers are now available that are injected more deeply, resulting in the restoration of supportive structure and foundation. These can be used in combination with other products that are used more superficially for smoothing skin surfaces. As numerous soft tissue fillers enter the market, mechanisms and injection techniques become more divergent, and therefore require that the dermatologist and cosmetic surgeon receive adequate training to use products safely and effectively. This manuscript provides an overview of soft tissue fillers and their proper use.
引用
收藏
页码:349 / 355
页数:7
相关论文
共 24 条
[1]
Alster T, 2004, AGING FACE MORE SKIN
[2]
Full scope of effect of facial lipoatrophy: A framework of disease understanding [J].
Ascher, Benjamin ;
Coleman, Sydney ;
Alster, Tina ;
Bauer, Ute ;
Burgess, Cheryl ;
Butterwick, Kimberly ;
Donofrio, Lisa ;
Engelhard, Peter ;
Goldman, Mitchel P. ;
Katz, Philippe ;
Vleggaar, Danny .
DERMATOLOGIC SURGERY, 2006, 32 (08) :1058-1069
[3]
NewFill for skin augmentation: A new filler or failure? [J].
Beljaards, RC ;
De Roos, KP ;
Bruins, FG .
DERMATOLOGIC SURGERY, 2005, 31 (07) :772-776
[4]
Bisaccia D, 1992, COSMETIC DERMATOL, V11, P8
[5]
NewFill for skin augmentation: A new filler or failure? [J].
Burgess, Cheryl M. ;
Lowe, Nick J. .
DERMATOLOGIC SURGERY, 2006, 32 (12) :1530-1532
[6]
Burgess CM, 2005, COSMETIC DERMATOLOGY, P93, DOI 10.1007/3-540-27333-6_6
[7]
Assessment of the safety and efficacy of poly-L-lactic acid for the treatment of HIV-associated facial lipoatrophy [J].
Burgess, CM ;
Quiroga, RM .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2005, 52 (02) :233-239
[8]
Collagen and injectable fillers [J].
Cheng, JT ;
Perkins, SW ;
Hamilton, MM .
OTOLARYNGOLOGIC CLINICS OF NORTH AMERICA, 2002, 35 (01) :73-+
[9]
Cheng JT, 2002, OTOLARYNGOL CLIN N A, V35, pvi
[10]
Fat distribution: a morphologic study of the aging face [J].
Donofrio, LM .
DERMATOLOGIC SURGERY, 2000, 26 (12) :1107-1112